- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Nov 4, 2025 | 3.56M sh |
| Shares Diluted | Q3 2026 · Sep 30, 2025 | 3.56M sh |
| Shares Diluted | Q3 2026 · Sep 30, 2025 | 3.55M sh |
| Shares Diluted | Q3 2026 · Sep 30, 2024 | 3.52M sh |
| Shares Diluted | Q3 2026 · Sep 30, 2024 | 3.51M sh |
| Stock Repurchased | Q3 2026 · Sep 30, 2025 | $269K |
| Stock Repurchased | Q3 2026 · Sep 30, 2024 | $0 |
| Capex | Q3 2026 · Sep 30, 2025 | $380K |
| Capex | Q3 2026 · Sep 30, 2024 | $219K |
| Operating Cash Flow | Q3 2026 · Sep 30, 2025 | $14.58M |
| Operating Cash Flow restated | Q3 2026 · Sep 30, 2024 | $3.61M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $101.49M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $94.74M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $86.14M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $89.99M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $81.62M |
| Stockholders Equity | Q3 2026 · Dec 31, 2023 | $78.32M |
| Total Liabilities | Q3 2026 · Sep 30, 2025 | $1.26B |
| Total Liabilities | Q3 2026 · Dec 31, 2024 | $1.22B |
| Total Assets | Q3 2026 · Sep 30, 2025 | $1.36B |
| Total Assets | Q3 2026 · Dec 31, 2024 | $1.3B |
| Eps Diluted | Q3 2026 · Sep 30, 2025 | $0.82 |
| Eps Diluted | Q3 2026 · Sep 30, 2025 | $2.35 |
| Eps Diluted | Q3 2026 · Sep 30, 2024 | $0.23 |
| Eps Diluted | Q3 2026 · Sep 30, 2024 | $1.44 |
| Net Income | Q3 2026 · Sep 30, 2025 | $2.92M |
| Net Income | Q3 2026 · Sep 30, 2025 | $8.34M |
| Net Income | Q3 2026 · Sep 30, 2024 | $792K |
| Net Income | Q3 2026 · Sep 30, 2024 | $5.03M |